Stone House Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9K Sell
54
-60
-53% -$16.6K ﹤0.01% 404
2026
Q1
$33.7K Buy
114
+35
+44% +$10.4K 0.01% 222
2025
Q4
$21.6K Buy
79
+24
+44% +$6.52K ﹤0.01% 247
2025
Q3
$14.9K Buy
55
+2
+4% +$544 ﹤0.01% 248
2025
Q2
$14.6K Hold
53
– – ﹤0.01% 232
2025
Q1
$14.1K Buy
+53
New +$13.1K ﹤0.01% 229
2024
Q4
– Sell
-53
Closed -$11.7K – 107
2024
Q3
$11.7K Hold
53
– – ﹤0.01% 214
2024
Q2
$10.4K Hold
53
– – ﹤0.01% 221
2024
Q1
$11.4K Buy
+53
New +$11.1K ﹤0.01% 221

Other funds holding CME

Stone House Investment Management's CME Position: Q2 2026 in Review

Stone House Investment Management reduced its CME Group (CME) stake by 53% in Q2 2026, selling an estimated $16.6K and leaving 54 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #404.

Stone House Investment Management first reported a position in CME in Q1 2024 and has held it in 9 quarters since. The position peaked at $33.7K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Stone House Investment Management held 54 shares of CME Group worth $11.9K as of Q2 2026.
  • Stone House Investment Management sold 60 CME Group shares in Q2 2026, an estimated $16.6K.
  • CME Group made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #404 holding.
  • Stone House Investment Management first reported a position in CME Group in Q1 2024 and has held it in 9 quarters since.
  • Stone House Investment Management's CME Group position peaked at $33.7K in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.